跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,404 条关于
“skeletal dysplasias”
全部
2,404
临床试验
2,020
药物
31
机构
2
资讯
351
去年
TYRA-300: Novel FGFR3-Selective Inhibitor Shows Promise in Urothelial Cancer and Achondroplasia
去年
BridgeBio Pharma's Acoramidis Shows Promise in Transthyretin Cardiomyopathy Trial
3年前
TYRA Biosciences Receives FDA Orphan Drug Designation for TYRA-300 in Achondroplasia
2年前
Infigratinib Receives FDA Breakthrough Therapy Designation for Achondroplasia
11年前
Tyra Biosciences Advances FGFR Inhibitor Pipeline with Multiple Clinical Trials
去年
FDA Clears Tyra Biosciences' TYRA-300 IND for Phase 2 Achondroplasia Trial
去年
BioMarin's VOXZOGO Shows Promising Results in Reducing Tibial Bowing in Children with Achondroplasia
18天前
BioMarin Secures 20% Royalty on Ascendis' Yuviwel in Global Patent Settlement
11个月前
Ascendis Pharma's Weekly CNP Therapy Challenges BioMarin's Daily Voxzogo in Achondroplasia Market
9天前
BridgeBio's Oral Infigratinib Shows Benefits Beyond Growth in Phase 3 PROPEL 3 Achondroplasia Trial
第 1 页,共 36 页
上一页
下一页